Board of Directors
Jeffrey Reynolds
Jeffrey Reynolds is the CEO and Chair of the Board of Cancer Prevention International. Jeff has over 25 years of disease research experience with over 10 years of experience in Oncology managing Breast, Gynelogical, and Gastrointestinal Cancer research programs.
In 1999 Jeff began doing Microbiology Reseach at the Perdue Farms Microbiology Research Laboratory where he demonstrated that Listeria and Salmonella Bacteriophages can successfully break up biofilms on surfaces. This work was featured in Smithsonian Magazine in 2001.
In 2001 Jeff came to Johns Hopkins University to expand into Cell and Molecular Biology research. Upon arrival at Johns Hopkins he began pushing for the use of Berkolderia and Psudomonas phages in the treatment of lung colonizations in Cystic Fibrosis patients. Jeff began specializing in primer design, real time PCR, and flow cytometry. This work was published in the American Journal of Respiratory Cell and Molecular Biology in 2006
2007 Jeff created the control cell line for the Ugandan women’s project to measure the HPV infection trends.
From 2007 to 2011 Jeff managed a large scale community health investigation into hypertension and hypercholesterolemia centered at 6 community health facilities. This work was published in the The New England Journal of Medicine in 2011.
In 2012 Jeff moved into Oncology, managing head and neck Cancer trials until 2016 when he began managing the Gastrointestinal Cancer Research Program.
In 2017 Jeff began managing the Breast and Ovarian Cancer Research Program and is currently managing that program. He also manages multi-disciplinary Cancer Research at Green Spring Station and manages the Breast Clinical Research Laboratory.
Jeff has served on numberous committees including the Johns Hopkins Oncology Education Committee and currently serves on the Johns Hopkins Oncology Safety Monitoring Committee.
Jeff holds a master’s degree in biotechnology from Johns Hopkins University and a Bachelor of Science degree from Salisbury State University.
Jeffrey Reynolds - Board Chair
Rose Parkinson
Rose Parkinson is a Senior Research Scientist and Regulatory Specialist at the Johns Hopkins School of Medicine GI Oncology Program. She manages communications with the US Food and Drug Administration and other regulatory bodies, ensures compliance with federal regulations, drafts clinical trial documents, and oversees data collection.
Rose attended the University of Pennsylvania for her bachelor’s degree, followed by Johns Hopkins University School of Medicine, where she received a Ph.D. in Immunology. She has over 20 years of medical research experience and more than 10 years of research experience in Gastrointestinal Cancers.
She has served on the board of Washington Hill Mutual Homes, a not-for-profit housing cooperative, and currently volunteers as Treasurer on the board of her local community association.
Like many people, Rose has had several close relatives diagnosed with cancer. She has joined the CPI board in order to share her professional experience and help CPI make cancer screenings more accessible for patients.
Rose Parkinson - Board Member
Al is a strategic pharmaceutical and biotech leader with two decades of experience leading inspection readiness activities focused on sponsor oversight of clinical operations across high-impact therapeutic areas, including oncology, rare diseases, cell and gene therapy, vaccines, respiratory, CNS, and medical devices. Atop a dependable GxP compliance and clinical operations foundation, he brings a unique ability to align operational execution with corporate vision, driving cross-functional optimization, risk mitigation, and process innovation. He has built a reputation for transforming complexity into clarity, developing methods to prioritize and quantify risk, and enhancing Trial Oversight models to enable consistency, efficiency, and global regulatory readiness across critical asset portfolios. He is also keenly aware of trends and the types of challenges faced by sponsor companies, having led numerous initiatives to assess inspection risks for critical assets and developing comprehensive mitigation plans. Al leads from the front by navigating the ever-evolving regulatory landscape to drive cross-functional inspection readiness initiatives at forward-thinking biotech and pharma companies. The direct effect is a continual improvement loop rooted in Quality by Design and Risk Management principles, that accelerates clinical development timelines by proactively embedding quality at every stage of the product lifecycle. And in this pursuit, Al is truly passionate about building and developing collaborative, high-performing teams that deliver results, and ultimately, hope to patients
Alberto Pacheco - Board MemberAl Pacheco
U. S. Operations Team
Jeffrey Reynolds
Jeffrey Reynolds is the CEO and Chair of the Board of Cancer Prevention International. Jeff has over 25 years of disease research experience with over 10 years of experience in Oncology managing Breast, Gynelogical, and Gastrointestinal Cancer research programs.
In 1999 Jeff began doing Microbiology Reseach at the Perdue Farms Microbiology Research Laboratory where he demonstrated that Listeria and Salmonella Bacteriophages can successfully break up biofilms on surfaces. This work was featured in Smithsonian Magazine in 2001.
In 2001 Jeff came to Johns Hopkins University to expand into Cell and Molecular Biology research. Upon arrival at Johns Hopkins he began pushing for the use of Berkolderia and Psudomonas phages in the treatment of lung colonizations in Cystic Fibrosis patients. Jeff began specializing in primer design, real time PCR, and flow cytometry. This work was published in the American Journal of Respiratory Cell and Molecular Biology in 2006
2007 Jeff created the control cell line for the Ugandan women’s project to measure the HPV infection trends.
From 2007 to 2011 Jeff managed a large scale community health investigation into hypertension and hypercholesterolemia centered at 6 community health facilities. This work was published in the The New England Journal of Medicine in 2011.
In 2012 Jeff moved into Oncology, managing head and neck Cancer trials until 2016 when he began managing the Gastrointestinal Cancer Research Program.
In 2017 Jeff began managing the Breast and Ovarian Cancer Research Program and is currently managing that program. He also manages multi-disciplinary Cancer Research at Green Spring Station and manages the Breast Clinical Research Laboratory.
Jeff has served on numberous committees including the Johns Hopkins Oncology Education Committee and currently serves on the Johns Hopkins Oncology Safety Monitoring Committee.
Jeff holds a master’s degree in biotechnology from Johns Hopkins University and a Bachelor of Science degree from Salisbury State University.
Chief Executive Officer
Chankanha Khuth Reynolds
Chankanha Khuth Reynolds was born and raised in Kandal Province Cambodia. Prior to moving to the United States Kanha worked as a Tailor in Phnom Penh. Her work can be seen in hotels and restaurants in Phnom Penh and Siem Reap and is worn by customers in Cambodia, France, and Germany. Kanha has a wealth of experience in managing and completing projects for national and international customers on tight deadlines.
Director
DirectorJennifer Lehman
Jennifer Lehman serves as Director of Operations for Cancer Prevention International.
Jenn has over 10 years of Cancer Research experience.
She started her career at Moffitt Cancer Center in Tampa, Florida as a Research Coordinator enrolling patients to their Total Cancer Care Protocol, a large biorepository initiative that collected patient data, tissue and blood samples from patients seeking care at the Cancer Center.
Since moving to Maryland in 2015, Jenn has been working in the Breast and Gynecologic Cancer Research Program at Johns Hopkins University. She initially served as a Research Coordinator working directly with patients undergoing surgery and treatment for breast cancer. She has extensive experience in identifying patients for trials and speaking with patients about how their data and samples contribute to important research for future patients. Jenn is now a Research Program Manager and oversees the staff and portfolio of clinical research studies within the Breast and Gynecologic Cancer Research Program. She is well-versed in hiring and coaching clinical research staff and tracking departmental metrics.
Jenn earned her Bachelor of Science in Molecular Biology from Millersville University of Pennsylvania.
Cambodia Operations Team
TBD
As the lead representative in Cambodia, the Director will be responsible for all operations, financial, and regulatory filings.
Director
TBD
The Community Programs Manager will be responsible for leading Education, relief, and support programs.
Manager Community Programs
Manager of CommunicationsTBD
The Communications Manger will be responsible for relaying mission and purpose of CPI.
Our Vision
Our vision is a world where cancer care and survival are equitable for all.
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!